🌟A masterclass in microvascular physiology by Dr. Jonathan Lindner followed by,

🌟 @prodriguezmd.bsky.social and Dr. Olga Toleva discussing
✅️The importance of endotyping of NOCAs and the role of coronary function testing to guide targeted therapies in enabling
#PrecisionMedicine

🌟Bottom Line? We need MORE RESEARCH

@scct-heart.bsky.social
@drmarthagulati.bsky.social
@mgbwomenheart.bsky.social
@erinmichos.bsky.social

💠👭 can have higher CT-FFR for the same stenosis severity! Use it to reduce sex disparities, and avoid unnecessary caths.

💠 #yesCCT has the potential to bridge knowledge gaps in #womensCVD

💠 We must carefully consider sex hormone exposures and associated #CV risk in our transgender patients!

💠 #yesCCT can be more prognostic in 👭!

💠 Asymptomatic 👭 develop #CAC 10 years behind men, but symptomatic 👭 only lag by 5 years in plaque by CCTA

🌟Bottom Line? We need MORE RESEARCH

@scct-heart.bsky.social
@drmarthagulati.bsky.social
@mgbwomenheart.bsky.social
@erinmichos.bsky.social

💠👭 can have higher CT-FFR for the same stenosis severity! Use it to reduce sex disparities, and avoid unnecessary caths.

💠 #yesCCT has the potential to bridge knowledge gaps in #womensCVD

💠 We must carefully consider sex hormone exposures and associated #CV risk in our transgender patients!

💠 #yesCCT can be more prognostic in 👭!

💠 Asymptomatic 👭 develop #CAC 10 years behind men, but symptomatic 👭 only lag by 5 years in plaque by CCTA

❎️ Is currently too expensive and perhaps not ready for primetime with no RCT data supporting widespread adoption.

@scct-heart.bsky.social @saraersozlu.bsky.social @prodriguezmd.bsky.social @purviparwani.bsky.social

✅️ CCTA guidance improves CTO outcomes.

✅️ Plaque physiology, myocardial mass at risk determined by CCTA helps guide bifurcation PCI.

@scct-heart.bsky.social @faroucjaffer.bsky.social @yadersandoval.bsky.social